Mirum Pharmaceuticals, Inc. (MIRM)
90.65
+0.21
(+0.23%)
USD |
NASDAQ |
Jan 14, 16:00
90.01
-0.64
(-0.71%)
Pre-Market: 09:18
Mirum Pharmaceuticals SG&A Expense (TTM): 239.73M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.91B |
| XOMA Royalty Corp. | 32.68M |
| Arcutis Biotherapeutics, Inc. | 253.18M |
| Recursion Pharmaceuticals, Inc. | 220.12M |
| Insmed, Inc. | 631.20M |